Nursing Pharmacology: Antiviral Drugs

Previous Page Page Forward
Section Table of Contents
Site Table of Contents
Previous Page Page Forward
Section Table of Contents
Site Table of Contents

References

  1. Acosta EP Flexner C Antiviral Agents (Nonretroviral) Chapter 58 in Goodman & Gilman's The Pharmacological Basis of Therapeutics, 12th edition (Brunton LL Chabner BA Knollmann BC, eds; Brunton LL, ed; Blumenthal DK  Murri N Hilal-Dandan R, assoc eds, Knollmann BC, consulting ed, on-line edition) The McGraw-Hill Companies, 2011.

  2. Baden LR Dolin R, Chapter 178, Antiviral Chemotherapy, Excluding Antiretroviral Drugs, in Harrison's Online   (Dan L. Longo, Anthony S. Fauci, Dennis L. Kasper, Stephen L. Hauser, J. Larry Jameson, Joseph Loscalzo, Eds.),  Harrison's Principles of Internal Medicine, 18th edition, The McGraw-Hill Companies, Inc. 2012.

  3. Safrin S Antiviral Agents, Chapter 49 in Basic & Clinical Pharmacology, 12 e (Katzung BG Masters SB Trevor AJ) The McGraw-Hill Companies, 2012 (on-line edition)

  4. Briedis DJ  Chapter 18:  Influenza Viruses  (in Acheson NH,  Fundamentals of molecular virology, 2nd edition) p. 210-220 2011.

  5. Dolin R Chapter 187, Influenza , in Harrison's Online   (Dan L. Longo, Anthony S. Fauci, Dennis L. Kasper, Stephen L. Hauser, J. Larry Jameson, Joseph Loscalzo, Eds.),  Harrison's Principles of Internal Medicine, 18th edition, The McGraw-Hill Companies, Inc. 2012.

  6. Mouagip (derivative work):  Illustration of Antigenic Shift (National Institute of Allergy and Infectious Diseases) http://commons.wikimedia.org/wiki/File:AntigenicShift_HiRes_vector.svg

  7. Davies WL Brunert RR Haff RF McGahen JW Neumayer EM Paulshock M Watts JC Wood TR Hermann EC Hoffmann CE Antiviral Activity of 1-Adamantanamine (Amantadine) Science 144 (3620): 862-863, May 15, 1964.

  8. Rabinovich S Baldini JT Bannister R Treatment of influenza.  The therapeutic efficacy of rimantidine HCl in a naturally occurring influenza A2 outbreak.  Am J Med Sci 257:  328-355, 1969.

  9. Wang J Ma C Wang J Jo H Canturk B Fiorin G Pinto LH Lamb RA Klein ML DeBrado WF Discovery of novel dual inhibitors of the wild-type and the most prevalent drug-resistant mutant, S31N of the M2 protein channel from influenza A virus. J Med Chem 56:  2804-2812, 2013.

  10. Eeinger TO Pohl MO Stertz S Entry of influenza A virus:  host factors and antiviral targets Journal of General Virology 95:  263-277 (2014).

  11. Krug RM Aramini JM Emerging antiviral targets for influenza A virus.  Trends in Pharmacological Sciences 30(6): 266-277 June 2009.

  12. Racaniello V:  Virology blog about viruses and viral disease. Adapted from "Release of influenza viral RNAs into Cells (6 May 2009).  http://www.virology.ws/2009/05/06/release-of-influenza-viral-rnas-into-cells/

 

Disclaimer

This Web-based pharmacology and disease-based integrated teaching site is based on reference materials, that are believed reliable and consistent with standards accepted at the time of development. Possibility of human error and on-going research and development in medical sciences do not allow assurance that the information contained herein is in every respect accurate or complete. Users should confirm the information contained herein with other sources. This site should only be considered as a teaching aid for undergraduate and graduate biomedical education and is intended only as a teaching site. Information contained here should not be used for patient management and should not be used as a substitute for consultation with practicing medical professionals. Users of this website should check the product information sheet included in the package of any drug they plan to administer to be certain that the information contained in this site is accurate and that changes have not been made in the recommended dose or in the contraindications for administration.  Advertisements that appear on this site are not reviewed for content accuracy and it is the responsibility of users of this website to make individual assessments concerning this information.  Medical or other information  thus obtained should not be used as a substitute for consultation with practicing medical or scientific or other professionals.